Roughly three-quarters of menstruating people experience some form of premenstrual syndrome, but the symptoms vary enormously in severity. For many, lifestyle adjustments and over-the-counter options are enough. For others, premenstrual syndrome medication becomes part of how the second half of the cycle gets managed. The challenge is that the right premenstrual syndrome medication depends entirely on which symptoms are bothering you most, and most overview articles do not connect medications to symptoms in a useful way.
This article walks through premenstrual syndrome medication by symptom category, which is the framing that actually helps you and a prescriber decide what to try. It covers SSRIs for emotional symptoms, NSAIDs for physical pain, hormonal birth control for cyclical symptom suppression, spironolactone and other diuretics for fluid retention, supplements with reasonable evidence, and what to skip because the evidence does not support it. By the end you should have a clear picture of which premenstrual syndrome medication categories address which problems and what to discuss with your clinician.
Premenstrual syndrome medication: when treatment is worth it
Premenstrual syndrome affects most menstruating people, but most do not need premenstrual syndrome medication. For mild to moderate PMS, lifestyle adjustments often produce adequate relief: regular aerobic exercise, consistent sleep, reduced caffeine and alcohol, reduced sodium, and stress management. Over-the-counter pain relievers cover the physical discomfort for many people.
Premenstrual syndrome medication becomes worth considering when symptoms regularly disrupt work, relationships, or daily function despite lifestyle adjustments. The threshold is not about how unpleasant the symptoms feel; it is about whether they meaningfully interfere with your ability to function in the second half of every cycle. If you find yourself canceling commitments, struggling at work, or having difficult interactions with family members in the luteal phase month after month, premenstrual syndrome medication is reasonable to discuss with a clinician.
One important distinction matters before considering any premenstrual syndrome medication. PMS and PMDD are different conditions, with different severity thresholds and different treatment expectations. Premenstrual syndrome medication is generally aimed at moderate-to-severe PMS, meaning symptoms that are uncomfortable and disruptive but do not reach the level of severe emotional impairment that defines PMDD. If your emotional symptoms include severe depression, rage that frightens you, suicidal thoughts, or complete inability to function, the right framework is PMDD evaluation and treatment rather than PMS medication. For more on the distinction, see PMDD vs PMS: Key Differences, Symptoms, and How to Get a Diagnosis.
Premenstrual syndrome medication by symptom category
Most articles list premenstrual syndrome medication by drug class. The more useful framing is by symptom, because the medications work very differently and the right choice depends entirely on which symptoms are bothering you.
For emotional symptoms (irritability, mood, anxiety, low mood): SSRIs are the first-line premenstrual syndrome medication. They have the strongest evidence base, the fastest onset of action, and flexible dosing options that work specifically for cyclical symptoms.
For physical pain (cramps, headache, body aches): NSAIDs are the first-line option. Ibuprofen, naproxen, or mefenamic acid taken starting one to two days before expected period onset typically produces better results than waiting until symptoms peak.
For bloating and water retention: Spironolactone in the luteal phase has the best evidence among diuretics. Other diuretics are sometimes used but produce less consistent results.
For breast tenderness: NSAIDs help. Spironolactone helps. Hormonal contraception helps some people and worsens it in others.
For cyclical mood symptoms in someone who needs contraception: Hormonal birth control, particularly drospirenone-containing combined oral contraceptives, can address both contraception and PMS symptoms in one approach.
For multiple severe symptoms: Combination treatment is common, such as SSRI plus NSAID plus targeted physical-symptom medication, or hormonal contraception plus SSRI for those who respond partially to either alone.
This symptom-based framing is the framework most clinicians use when discussing premenstrual syndrome medication. The categories below cover each option in more depth.
SSRIs: the strongest evidence among premenstrual syndrome medication
Selective serotonin reuptake inhibitors are the most evidence-supported premenstrual syndrome medication for emotional symptoms. Three SSRIs hold specific FDA approval for premenstrual symptoms in their PMDD indication: fluoxetine (Prozac, also marketed as Sarafem for PMDD), sertraline (Zoloft), and paroxetine controlled-release (Paxil CR). Other SSRIs, including citalopram (Celexa) and escitalopram (Lexapro), are commonly used off-label with similar effectiveness in clinical practice. These antidepressants act on serotonin to address the cyclical mood symptoms specifically, and FDA approval for the PMDD indication extends to severe PMS in clinical practice.
Doses for premenstrual symptoms are typically lower than doses used to treat depression. Fluoxetine for PMS is often started at 10 to 20 mg, sertraline at 25 to 50 mg, and paroxetine CR at 12.5 mg. Some people require higher doses for full symptom control, but the lower starting point reflects how rapidly SSRIs work for cyclical symptoms.
Unlike depression treatment, where SSRIs take four to six weeks to produce full effect, SSRIs used as premenstrual syndrome medication often produce noticeable improvement within days. This makes two dosing strategies possible. Continuous dosing means taking the SSRI every day, regardless of cycle phase. Luteal-phase dosing means taking the SSRI only during the two weeks before expected menstruation, then stopping when the period begins.
Continuous dosing is typically recommended for more severe symptoms, for people with irregular cycles, or for people who prefer the simplicity of daily dosing. Luteal-phase dosing reduces overall medication exposure and side effect burden, works for people with predictable cycles, and is reasonable for moderate symptoms. The choice between them is individual and benefits from a conversation with a clinician who can review your specific situation.
Common SSRI side effects include nausea (typically in the first two weeks), changes in sleep, sexual side effects (decreased libido, delayed orgasm), and reduced appetite. Side effects sometimes drive the choice between SSRIs and the dosing strategy used.
NSAIDs and other premenstrual syndrome medication for physical symptoms
For physical PMS symptoms (cramps, headache, body aches, joint pain), nonsteroidal anti-inflammatory drugs (NSAIDs) are first-line premenstrual syndrome medication. The most commonly used options include ibuprofen (Advil, Motrin), naproxen (Aleve), and for more severe cramping, mefenamic acid (Ponstel, available by prescription only).
The timing of NSAID dosing matters significantly. Most people start taking NSAIDs once symptoms become uncomfortable, which is later than ideal. Starting NSAIDs one to two days before expected period onset and continuing through the first few days of menstruation typically produces better cramp control than waiting for symptoms to peak. NSAIDs work by inhibiting prostaglandin production, which causes much of the cramping pain, so prevention is more effective than reaction.
For physical symptoms that NSAIDs do not adequately address, prescription options exist. Mefenamic acid is particularly effective for severe menstrual cramping. Some patients benefit from short courses of higher-dose NSAIDs (under medical supervision) at the peak of symptom severity. Combined hormonal contraception suppresses ovulation entirely and often reduces or eliminates menstrual cramping over several cycles of use.
Acetaminophen (Tylenol) can be used for PMS-related headache and is appropriate for people who cannot tolerate NSAIDs due to GI sensitivity, kidney issues, or other contraindications. Acetaminophen is less effective than NSAIDs for cramping specifically because it does not affect prostaglandin production.
Hormonal birth control as premenstrual syndrome medication
Hormonal contraception is another premenstrual syndrome medication option, particularly for people who need contraception anyway and whose PMS symptoms have a strong cyclical pattern.
Combined oral contraceptives (containing both estrogen and progestin) work for PMS by suppressing ovulation, which suppresses the cyclical hormonal shifts that produce many premenstrual symptoms. The strongest evidence for PMS specifically is for drospirenone-containing combined oral contraceptives (Yaz, Beyaz, Yasmin, and their generics). Drospirenone has anti-androgenic and anti-mineralocorticoid properties that distinguish it from progestins in other formulations, and the 24/4 dosing schedule of Yaz minimizes the hormone-free interval that can trigger a mini-PMS episode each cycle.
Continuous dosing (skipping the placebo week and taking active pills indefinitely) typically produces better PMS results than standard 21/7 cyclic dosing. This is the same principle that makes continuous dosing useful for PMDD: the more completely the cyclical hormonal shifts are suppressed, the better the cyclical symptoms tend to respond. Breakthrough bleeding in the first three to six months of continuous dosing is common; after the adjustment period, most users develop amenorrhea (no period at all).
The honest caveat about hormonal birth control as premenstrual syndrome medication: it does not work for everyone. Some people feel worse on combined oral contraceptives, particularly in the first few cycles. Progestin-only methods (mini-pill, hormonal IUDs like Mirena, the contraceptive implant, and Depo-Provera) have weaker evidence for PMS and can worsen mood in some people. If you have a history of mood worsening on hormonal contraception, an SSRI is typically the better starting point.
For more on hormonal birth control as treatment for cyclical mood disorders, see Birth Control for PMDD: Does It Help? What the Evidence Says.
Spironolactone, diuretics, and other targeted premenstrual syndrome medication options
For specific physical symptoms (bloating, water retention, breast tenderness, weight fluctuation in the luteal phase), spironolactone is the best-evidenced premenstrual syndrome medication. It is a potassium-sparing diuretic that also has anti-androgen effects.
Spironolactone is typically dosed at 50 to 100 mg per day during the luteal phase (roughly the two weeks before menstruation) and stopped when the period begins. This luteal-phase-only dosing minimizes overall medication exposure while addressing the specific window when fluid retention symptoms appear. Some clinicians use spironolactone continuously rather than luteal-phase only, particularly if the patient also has other indications for the medication (acne, polycystic ovary syndrome features).
Other diuretics (hydrochlorothiazide, furosemide) are sometimes used for PMS bloating but produce less consistent results than spironolactone and are not typically first-line. Over-the-counter “water pills” sold in pharmacies for menstrual bloating are usually weak diuretics with marginal evidence.
For severe treatment-resistant cases of premenstrual symptoms, gonadotropin-releasing hormone (GnRH) agonists can suppress ovarian function entirely, producing a temporary medical menopause. These are reserved for severe cases (more typical for PMDD than for PMS), produce significant menopausal side effects, and require add-back hormone therapy if used long-term. They are not a routine premenstrual syndrome medication.
Premenstrual syndrome medication and supplements: what’s worth trying
Several supplements have reasonable evidence as premenstrual syndrome medication, particularly for mild symptoms or alongside prescription treatment.
Calcium (1,200 mg per day) has the strongest supplement evidence for premenstrual symptoms. A large multicenter randomized trial showed calcium supplementation reduced both physical and emotional PMS symptoms by roughly 50 percent over three cycles. Most people get some calcium from diet, so a supplement dose of 500 to 1,000 mg added to dietary intake usually reaches the studied dose.
Vitamin B6 (50 to 100 mg per day) has modest evidence for PMS mood symptoms. Doses above 100 mg per day taken chronically can cause peripheral neuropathy, so staying at or below 100 mg matters.
Magnesium (200 to 360 mg per day) has mixed evidence. Magnesium glycinate is the form most commonly recommended and is well tolerated.
Chasteberry (Vitex agnus-castus, 20 to 40 mg of standardized extract daily) has moderate evidence for PMS symptoms, particularly irritability, breast tenderness, and headache.
These supplements work best as adjuncts to prescription premenstrual syndrome medication, not as replacements for moderate-to-severe symptoms. For mild PMS, they may be sufficient on their own. For a deeper look at supplement evidence specifically for premenstrual conditions, see PMDD Supplements: What Works, What Doesn’t.
What doesn’t work as premenstrual syndrome medication
Several commonly recommended approaches do not have evidence supporting their use as premenstrual syndrome medication, and avoiding them saves money and time.
Progesterone supplementation does not work for PMS or PMDD. The underlying problem in premenstrual symptoms is not progesterone deficiency, so supplementing progesterone does not address the mechanism. Multiple randomized trials show progesterone is no more effective than placebo for premenstrual symptoms.
Diuretics for emotional symptoms do not work. Diuretics can reduce physical bloating but do not address the mood, irritability, or anxiety components of PMS.
Anti-anxiety medications alone as PMS treatment do not work well. Benzodiazepines can reduce specific anxiety symptoms in the moment but do not address the underlying cyclical mechanism and carry significant dependence risks. They are not appropriate first-line premenstrual syndrome medication.
Most herbal supplements marketed for premenstrual symptoms have weak or no evidence. Evening primrose oil, St. John’s Wort, dong quai, black cohosh, wild yam, and proprietary “PMS blends” all fall into this category. St. John’s Wort specifically can interact dangerously with hormonal birth control (reducing contraceptive effectiveness) and with SSRIs (risk of serotonin syndrome), so it is worth flagging as a supplement to avoid if you are taking other premenstrual syndrome medication.
High-dose vitamin E and zinc are sometimes recommended without strong evidence. Modest doses as part of a general multivitamin are fine; high doses targeted at PMS specifically are not well-supported.
The supplement and over-the-counter market has been profitable for decades, and the marketing for many of these products is more persuasive than the underlying evidence. If you have been spending money on supplements that have not produced meaningful relief, the evidence is not on the side of continuing them.
When premenstrual syndrome medication isn’t enough, and PMDD becomes the question
If you have tried premenstrual syndrome medication appropriately (an SSRI at an adequate dose, hormonal contraception, or combinations) and your symptoms continue to disrupt your life, the question shifts from PMS to PMDD. The two conditions share underlying biology but differ in severity, and the diagnostic and treatment process differs accordingly.
Signs that your symptoms may be PMDD rather than PMS include severe emotional symptoms (rage, hopelessness, suicidal thoughts, severe anxiety) in the luteal phase, complete resolution of symptoms within a few days of your period starting, regular disruption to work and relationships that goes beyond inconvenience, and persistent symptoms despite first-line premenstrual syndrome medication.
For someone whose symptoms are at the PMDD end of the spectrum, the evaluation involves prospective symptom tracking across at least two cycles, careful screening for co-occurring mental health conditions, and a more targeted treatment plan. See How Is PMDD Diagnosed? Tests, Criteria, and What to Expect for what that diagnostic process looks like, and PMDD Medication: SSRIs, Birth Control, and Other Treatments Compared for treatment options at the PMDD level.
When to take the next step
If your premenstrual symptoms are regularly disrupting your work, relationships, or daily life and lifestyle changes have not been enough, premenstrual syndrome medication is worth considering. The right choice depends on which symptoms are bothering you most, your reproductive plans, your history with antidepressants or hormonal medications, and what you can tolerate in terms of side effects.
I provide precision psychiatry and medication management for patients in New Jersey (in-person at Fort Lee) and New York (telehealth), including specialized care for premenstrual syndrome treatment and PMDD treatment. Initial consultations are 50 minutes and cover your full picture: symptom pattern, what you have already tried, reproductive plans, and what a tailored plan looks like.
For trusted general reference on premenstrual syndrome and treatment options, the American College of Obstetricians and Gynecologists (ACOG) Premenstrual Syndrome page is a reliable starting point.
